Younger haplo-donors improve older patient survival outcomes.
作者信息
Ghorab Ahmad, Luznik Leo
机构信息
Division of Hematology and Oncology, Baylor College of Medicine, Dan L Duncan Comprehensive Cancer Center, Houston, TX.
出版信息
Blood Adv. 2025 Jul 8;9(13):3308-3309. doi: 10.1182/bloodadvances.2025016335.
Abstract
摘要
相似文献
1
Younger haplo-donors improve older patient survival outcomes.年轻的单倍体供者可改善老年患者的生存结局。
Blood Adv. 2025 Jul 8;9(13):3308-3309. doi: 10.1182/bloodadvances.2025016335.
2
Impact of haplo-donor age on transplant outcomes: a comparative analysis of haploidentical vs cord blood transplantation.单倍体供者年龄对移植结局的影响：单倍体相合移植与脐血移植的比较分析
Blood Adv. 2025 Jul 8;9(13):3226-3237. doi: 10.1182/bloodadvances.2024014938.
3
Outcomes of Human Leukocyte Antigen-Matched Related Donor and Haploidentical Allogeneic Hematopoietic Cell Transplantation Recipients by Immune Profiles of Recipients and Donors.根据受者和供者的免疫特征分析人类白细胞抗原匹配的相关供者及单倍体相合异基因造血细胞移植受者的结局
Transplant Cell Ther. 2024 Aug;30(8):808.e1-808.e13. doi: 10.1016/j.jtct.2024.05.018. Epub 2024 May 25.
4
Allogeneic hematopoietic cell transplantation for older patients with AML with active disease. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).异基因造血细胞移植治疗有活动疾病的老年 AML 患者。来自欧洲血液和骨髓移植学会（EBMT）急性白血病工作组的一项研究。
Bone Marrow Transplant. 2024 Jul;59(7):983-990. doi: 10.1038/s41409-024-02275-6. Epub 2024 Mar 30.
5
Haploidentical Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide and Peripheral Blood Stem Cell Grafts in Older Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome.老年急性髓系白血病或骨髓增生异常综合征患者采用亲缘单倍体造血干细胞移植联合移植后环磷酰胺和外周血造血干细胞移植。
Biol Blood Marrow Transplant. 2017 Oct;23(10):1736-1743. doi: 10.1016/j.bbmt.2017.06.019. Epub 2017 Jul 5.
6
Optimizing Haploidentical Hematopoietic Stem Cell Transplantation: Enhancing Outcomes in Hematologic Malignancies in Resource-Limited Settings.优化单倍型相合造血干细胞移植：改善资源有限环境下血液系统恶性肿瘤的治疗结局
J Blood Med. 2025 Mar 30;16:151-161. doi: 10.2147/JBM.S511039. eCollection 2025.
7
Transplant outcomes using older matched sibling donors compared with young alternative donors: a CIBMTR analysis.与年轻的替代供体相比，使用年长的匹配同胞供体的移植结果：一项国际骨髓移植登记处（CIBMTR）的分析
Blood Adv. 2025 Jul 22;9(14):3469-3478. doi: 10.1182/bloodadvances.2024014858.
8
Alternative donor transplantation--"mixing and matching": the role of combined cord blood and haplo-identical donor transplantation (haplo-cord SCT) as a treatment strategy for patients lacking standard donors?替代供体移植——“混合与匹配”：联合脐血和单倍体相合供体移植（单倍体-脐血造血干细胞移植）作为缺乏标准供体患者的治疗策略的作用？
Curr Hematol Malig Rep. 2015 Mar;10(1):1-7. doi: 10.1007/s11899-014-0245-y.
9
Transplant Outcomes in Myelofibrosis: Impact of Donor Type (Cord Blood Grafts Supported by CD34+ selected Cells [Haplo-Cord] Versus Matched Donors).骨髓纤维化的移植结果：供者类型的影响（CD34+细胞选择的脐带血移植物[单倍体-脐带血]与匹配供者）。
Transplant Cell Ther. 2024 Nov;30(11):1100.e1-1100.e11. doi: 10.1016/j.jtct.2024.08.023. Epub 2024 Sep 5.
10
Incidence, Risk Factors, and Outcomes of BK Hemorrhagic Cystitis in Hematopoietic Stem Cell Transplantation From HLA-Matched and Haploidentical Donors With Post-Transplant Cyclophosphamide.接受移植后环磷酰胺的 HLA 匹配和单倍体相合供者造血干细胞移植中 BK 出血性膀胱炎的发病率、危险因素及结局
Transplant Cell Ther. 2025 Mar;31(3):182.e1-182.e11. doi: 10.1016/j.jtct.2024.12.006. Epub 2024 Dec 17.
本文引用的文献
1
Impact of haplo-donor age on transplant outcomes: a comparative analysis of haploidentical vs cord blood transplantation.单倍体供者年龄对移植结局的影响：单倍体相合移植与脐血移植的比较分析
Blood Adv. 2025 Jul 8;9(13):3226-3237. doi: 10.1182/bloodadvances.2024014938.
2
In 2022, which is preferred: haploidentical or cord transplant?2022 年，更推荐使用半相合还是脐带血移植？
Hematology Am Soc Hematol Educ Program. 2022 Dec 9;2022(1):64-73. doi: 10.1182/hematology.2022000327.
3
Haploidentical transplantation with post-transplant cyclophosphamide versus single cord blood transplantation for myelodysplastic syndrome: A retrospective study from the Adult Myelodysplastic Syndrome Working Group of the Japanese Society for Transplantation and Cellular Therapy (JSTCT).单倍体相合移植联合移植后环磷酰胺与单份脐血移植治疗骨髓增生异常综合征：日本移植与细胞治疗学会（JSTCT）成人骨髓增生异常综合征工作组的一项回顾性研究
Am J Hematol. 2022 Dec;97(12):E447-E450. doi: 10.1002/ajh.26722. Epub 2022 Sep 22.
4
Comparable survival outcomes with haploidentical stem cell transplantation and cord blood transplantation.与单倍体相合干细胞移植和脐带血移植相比具有可比的生存结果。
Bone Marrow Transplant. 2022 Nov;57(11):1681-1688. doi: 10.1038/s41409-022-01770-y. Epub 2022 Aug 20.
5
Comparison of haploidentical and umbilical cord blood transplantation after myeloablative conditioning.清髓性预处理后单倍体相合与脐带血移植的比较。
Blood Adv. 2021 Oct 26;5(20):4064-4072. doi: 10.1182/bloodadvances.2021004462.
6
Relationship of donor age and relationship to outcomes of haploidentical transplantation with posttransplant cyclophosphamide.供者年龄和与环磷酰胺后移植相关的关系与单倍体相合移植结果的关系。
Blood Adv. 2021 Mar 9;5(5):1360-1368. doi: 10.1182/bloodadvances.2020003922.
7
Impact of donor age and kinship on clinical outcomes after T-cell-replete haploidentical transplantation with PT-Cy.供体年龄和亲属关系对采用PT-Cy的T细胞充足单倍体移植后临床结局的影响。
Blood Adv. 2020 Aug 25;4(16):3900-3912. doi: 10.1182/bloodadvances.2020001620.
8
Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide.供者特征对移植后环磷酰胺的单倍体相合移植的影响。
Blood Adv. 2018 Feb 13;2(3):299-307. doi: 10.1182/bloodadvances.2017014829.
9
Donor age determines outcome in acute leukemia patients over 40 undergoing haploidentical hematopoietic cell transplantation.供者年龄决定了 40 岁以上接受单倍体造血细胞移植的急性白血病患者的结局。
Am J Hematol. 2018 Feb;93(2):246-253. doi: 10.1002/ajh.24963. Epub 2017 Dec 6.
10
Modern approaches to HLA-haploidentical blood or marrow transplantation.HLA单倍型相合血液或骨髓移植的现代方法。
Nat Rev Clin Oncol. 2016 Jan;13(1):10-24. doi: 10.1038/nrclinonc.2015.128. Epub 2015 Aug 25.
Zotero 插件